Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2023.1145994
Abstract: Background: Imbalance between cell proliferation and apoptosis underlies the development of pulmonary arterial hypertension (PAH). Current vasodilator treatment of PAH does not target the uncontrolled proliferative process in pulmonary arteries. Proteins involved in the apoptosis… read more here.
Keywords: ym155; bcl2 mki67; expression survivin; pah ... See more keywords